Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

11.72USD
16 Feb 2018
Change (% chg)

$0.32 (+2.81%)
Prev Close
$11.40
Open
$11.36
Day's High
$11.97
Day's Low
$11.23
Volume
28,782
Avg. Vol
25,948
52-wk High
$13.91
52-wk Low
$6.24

Select another date:

Mon, Nov 13 2017

BRIEF-AC Immune SA reports quarterly ‍loss per share CHF 0.15

* AC Immune SA reports third quarter 2017 financial results and corporate update

BRIEF-AC Immune SA to receive milestone payment for anti-tau antibody moving into phase 2 trial for alzheimer's disease

* AC Immune SA to receive milestone payment for anti-tau antibody moving into phase 2 trial for Alzheimer's Disease

BRIEF-AC Immune to get milestone payment for Alzheimer drug

* Says to receive milestone payment for anti-tau antibody moving into phase 2 trial for Alzheimer's disease ‍​

BRIEF-AC Immune to present at two investor conferences and provide scientific updates at CTAD conference

* AC Immune to present at two investor conferences and provide scientific updates at CTAD conference Source text for Eikon: Further company coverage:

BRIEF-AC Immune completes recruitment for low-dose cohort in world's first clinical trial for Anti-Abeta Vaccine

* AC Immune completes recruitment for low-dose Cohort in world's first clinical trial for Anti-Abeta Vaccine targeting alzheimer's disease-like characteristics in individuals with down syndrome Source text for Eikon: Further company coverage:

Select another date: